Nieswandt, Bernhard

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Nature Medicine

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 398

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration

Cloutier, N., Allaeys, I., Marcoux, G., Machlus, K. R., Mailhot, B., Zufferey, A., Levesque, T., Becker, Y., Tessandier, N., Melki, I., et al. (2018) · Proceedings of the National Academy of Sciences

Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis Mechanisms

Cited by 219

Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice

Deppermann, C., Cherpokova, D., Nurden, P., Schulz, J.-N., Thielmann, I., Kraft, P., Vögtle, T., Kleinschnitz, C., Dütting, S., Krohne, G., et al. (2013) · Journal of Clinical Investigation

Platelet Disorders and TreatmentsBlood Coagulation and Thrombosis Mechanisms

Cited by 200

Ischaemic stroke: a thrombo‐inflammatory disease?

Nieswandt, B., Kleinschnitz, C., & Stoll, G. (2011) · The Journal of Physiology

Acute Ischemic Stroke ManagementPlatelet Disorders and Treatments

Cited by 192

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Flierl, U., Nero, T. L., Lim, B., Arthur, J. F., Yao, Y., Jung, S. M., Gitz, E., Pollitt, A. Y., Zaldivia, M. T. K., Jandrot-Perrus, M., et al. (2015) · Journal of Experimental Medicine

Platelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and Thrombosis

Cited by 114